Patents by Inventor Gabriel Victora

Gabriel Victora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERCELLULAR LABELING OF LIGAND-RECEPTOR INTERACTIONS
    Publication number: 20180346899
    Abstract: An sortase-mediated intercellular labeling method allowing for tracking ligand-receptor interaction both in vitro and in vivo; and uses thereof for tracking molecule interactions both in vitro and in vivo, identifying modulators of ligand-receptor interaction, identifying potential binding partners of a protein of interest, identifying B cells expressing high affinity B cell receptors to antigens, and identifying the antigen to which a T cell of interest binds.
    Type: Application
    Filed: August 3, 2018
    Publication date: December 6, 2018
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Giulia Pasqual, Gabriel Victora
  • Intercellular labeling of ligand-receptor interactions
    Patent number: 10053683
    Abstract: An sortase-mediated intercellular labeling method allowing for tracking ligand-receptor interaction both in vitro and in vivo; and uses thereof for tracking molecule interactions both in vitro and in vivo, identifying modulators of ligand-receptor interaction, identifying potential binding partners of a protein of interest, identifying B cells expressing high affinity B cell receptors to antigens, and identifying the antigen to which a T cell of interest binds.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: August 21, 2018
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: Giulia Pasqual, Gabriel Victora
  • INTERCELLULAR LABELING OF LIGAND-RECEPTOR INTERACTIONS
    Publication number: 20160097773
    Abstract: An sortase-mediated intercellular labeling method allowing for tracking ligand-receptor interaction both in vitro and in vivo; and uses thereof for tracking molecule interactions both in vitro and in vivo, identifying modulators of ligand-receptor interaction, identifying potential binding partners of a protein of interest, identifying B cells expressing high affinity B cell receptors to antigens, and identifying the antigen to which a T cell of interest binds.
    Type: Application
    Filed: October 5, 2015
    Publication date: April 7, 2016
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Giulia Pasqual, Gabriel Victora